Securities Daily Online News: On February 25, XinHua Medical responded to investor questions on the interactive platform, stating that the company’s replies are based on relevant data such as the number of contracts won to forecast business performance. The fundamental aspects of the company’s daily operations and core business layout have not undergone significant changes. The short-term fluctuations in performance in the third quarter of 2025 are mainly due to a decrease in investment income and other gains, as well as increased R&D investments, among other factors. For detailed operational information, please refer to the company’s periodic reports. Stock price fluctuations are influenced by multiple market factors. The company will focus on its main business development and earnestly protect the interests of all shareholders.
(Edited by Cong Kexin)
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Xinhua Medical: The fundamental elements such as the company's daily operations and core business layout have not undergone any fundamental changes.
Securities Daily Online News: On February 25, XinHua Medical responded to investor questions on the interactive platform, stating that the company’s replies are based on relevant data such as the number of contracts won to forecast business performance. The fundamental aspects of the company’s daily operations and core business layout have not undergone significant changes. The short-term fluctuations in performance in the third quarter of 2025 are mainly due to a decrease in investment income and other gains, as well as increased R&D investments, among other factors. For detailed operational information, please refer to the company’s periodic reports. Stock price fluctuations are influenced by multiple market factors. The company will focus on its main business development and earnestly protect the interests of all shareholders.
(Edited by Cong Kexin)